NO20090955L - BASB029-polynukleotid(er) og -polypeptider fra Neisseria meningitidis - Google Patents

BASB029-polynukleotid(er) og -polypeptider fra Neisseria meningitidis

Info

Publication number
NO20090955L
NO20090955L NO20090955A NO20090955A NO20090955L NO 20090955 L NO20090955 L NO 20090955L NO 20090955 A NO20090955 A NO 20090955A NO 20090955 A NO20090955 A NO 20090955A NO 20090955 L NO20090955 L NO 20090955L
Authority
NO
Norway
Prior art keywords
polypeptides
neisseria meningitidis
basb029
basb029 polynucleotide
polynucleotide
Prior art date
Application number
NO20090955A
Other languages
English (en)
Inventor
Jean-Louis Ruelle
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10831992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090955(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20090955L publication Critical patent/NO20090955L/no
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)

Abstract

Sammendrag Oppfinnelsen frembringer BASB029-polypeptider og -polynukleotider som koder for BASB029-polypeptider og fremgangsmåter for produksjon av slike polypeptider ved rekombinantteknikker. Det er også frembrakt diagnostiske, profylaktiske og terapeutiske anvendelser.
NO20090955A 1998-05-13 2009-03-02 BASB029-polynukleotid(er) og -polypeptider fra Neisseria meningitidis NO20090955L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810276.7A GB9810276D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003255 WO1999058683A2 (en) 1998-05-13 1999-05-07 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)

Publications (1)

Publication Number Publication Date
NO20090955L true NO20090955L (no) 2001-01-11

Family

ID=10831992

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20005696A NO326994B1 (no) 1998-05-13 2000-11-10 Polypeptid og fragmenter derav, polynukleotid, ekspresjonsvektor, vertscelle, fremgangsmate, vaksinesammensetning, anvendelse samt antistoff.
NO20090955A NO20090955L (no) 1998-05-13 2009-03-02 BASB029-polynukleotid(er) og -polypeptider fra Neisseria meningitidis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20005696A NO326994B1 (no) 1998-05-13 2000-11-10 Polypeptid og fragmenter derav, polynukleotid, ekspresjonsvektor, vertscelle, fremgangsmate, vaksinesammensetning, anvendelse samt antistoff.

Country Status (23)

Country Link
US (3) US6780419B1 (no)
EP (2) EP1078063B1 (no)
JP (2) JP4707832B2 (no)
KR (4) KR20100019461A (no)
CN (1) CN1322127C (no)
AT (1) ATE311457T1 (no)
AU (1) AU750032B2 (no)
BR (1) BR9910396A (no)
CA (1) CA2328403C (no)
CY (1) CY1105676T1 (no)
CZ (1) CZ299612B6 (no)
DE (1) DE69928658T2 (no)
DK (1) DK1078063T3 (no)
ES (1) ES2252946T3 (no)
GB (1) GB9810276D0 (no)
HU (1) HUP0102479A3 (no)
IL (2) IL139613A0 (no)
NO (2) NO326994B1 (no)
NZ (1) NZ508323A (no)
PL (1) PL197449B1 (no)
TR (1) TR200003347T2 (no)
WO (1) WO1999058683A2 (no)
ZA (1) ZA200006523B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
ATE446368T1 (de) † 1998-01-14 2009-11-15 Novartis Vaccines & Diagnostic Antigene aus neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
AU2457100A (en) * 1999-02-26 2000-09-14 Chiron S.P.A. Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
PT2275551E (pt) 1999-10-29 2015-06-29 Novartis Vaccines & Diagnostic Péptidos antigénicos de neisseria
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
ES2588917T3 (es) 2000-01-17 2016-11-07 Glaxosmithkline Biologicals Sa Vacuna de VME suplementada contra meningococo
AU2818101A (en) * 2000-01-25 2001-08-07 University Of Queensland, The proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
PT2270030E (pt) 2000-02-28 2012-07-24 Novartis Vaccines & Diagnostic Expressão heteróloga de proteínas de neisseria
ES2615362T3 (es) 2001-07-27 2017-06-06 Glaxosmithkline Biologicals Sa Adhesinas de meningococos
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
EP2351579B1 (en) 2002-10-11 2016-09-21 Novartis Vaccines and Diagnostics S.r.l. Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages
ES2397923T3 (es) 2003-10-02 2013-03-12 Novartis Ag Vacunas líquidas para múltiples serogrupos meningocócicos
US7459930B2 (en) * 2006-11-14 2008-12-02 Micron Technology, Inc. Digital calibration circuits, devices and systems including same, and methods of operation
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0916570D0 (en) 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
CA2792691A1 (en) 2010-03-11 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition or vaccine against gram-negative bacterial, for example, neisserial, infection or disease
JP6316755B2 (ja) * 2012-01-05 2018-04-25 ドイチェス クレープスフォルシュングスツェントルムＤｅｕｔｓｃｈｅｓ Ｋｒｅｂｓｆｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ Ｉｄｈ１ｒ１３２ｈ変異陽性がんを治療または診断する手段および方法
PL3491441T3 (pl) 2016-07-27 2020-10-05 Prysmian S.P.A. Giętka taśma światłowodowa

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
ATE446368T1 (de) 1998-01-14 2009-11-15 Novartis Vaccines & Diagnostic Antigene aus neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
NZ571167A (en) * 1999-04-30 2010-05-28 Novartis Vaccines & Diagnostic Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents

Also Published As

Publication number Publication date
JP4707832B2 (ja) 2011-06-22
CN1322127C (zh) 2007-06-20
ZA200006523B (en) 2001-11-12
IL139613A (en) 2014-03-31
KR20100019461A (ko) 2010-02-18
KR20080070073A (ko) 2008-07-29
NO20005696L (no) 2001-01-11
PL197449B1 (pl) 2008-03-31
JP2002514424A (ja) 2002-05-21
CN1309707A (zh) 2001-08-22
NO326994B1 (no) 2009-03-30
CA2328403C (en) 2013-11-05
GB9810276D0 (en) 1998-07-15
US6780419B1 (en) 2004-08-24
EP1078063B1 (en) 2005-11-30
EP1621623A2 (en) 2006-02-01
NZ508323A (en) 2002-10-25
KR20010043571A (ko) 2001-05-25
BR9910396A (pt) 2001-10-30
TR200003347T2 (tr) 2001-06-21
ATE311457T1 (de) 2005-12-15
PL345281A1 (en) 2001-12-03
WO1999058683A3 (en) 2000-04-06
AU4142099A (en) 1999-11-29
KR100897951B1 (ko) 2009-05-18
DK1078063T3 (da) 2006-04-03
JP2010166921A (ja) 2010-08-05
HK1036300A1 (en) 2001-12-28
IL139613A0 (en) 2002-02-10
NO20005696D0 (no) 2000-11-10
AU750032B2 (en) 2002-07-11
CZ299612B6 (cs) 2008-09-17
HUP0102479A2 (hu) 2001-10-28
US20040265332A1 (en) 2004-12-30
DE69928658D1 (de) 2006-01-05
EP1078063A2 (en) 2001-02-28
KR20060076789A (ko) 2006-07-04
CZ20004202A3 (en) 2001-05-16
HUP0102479A3 (en) 2004-10-28
EP1621623A3 (en) 2009-02-18
WO1999058683A9 (en) 2002-05-02
CA2328403A1 (en) 1999-11-18
ES2252946T3 (es) 2006-05-16
WO1999058683A2 (en) 1999-11-18
CY1105676T1 (el) 2010-12-22
US20090093622A1 (en) 2009-04-09
DE69928658T2 (de) 2006-06-14
KR100673674B1 (ko) 2007-01-23

Similar Documents

Publication Publication Date Title
NO20005696D0 (no) BASB029-polynukleotid(er) og polypeptider fra Neisseria Meningitidis
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
PL345793A1 (en) Neisseria meningitidis
PT1112366E (pt) Polinucleotideos e polipeptideos basb033 da neisseria meningitidis e suas utilizacoes
DK1163343T3 (da) Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer
WO2000043519A3 (en) Neisseria meningitidis polypeptides
GB9810285D0 (en) Novel compounds
GB9812440D0 (en) Novel compounds
AU4504999A (en) Novel compounds
DK1326982T3 (da) BASB205-polypeptider og polynukleotider kodende derfor
WO2000034482A3 (en) Novel compounds derived from neisseria meningitidis
AU4567300A (en) Novel compounds
GB0025170D0 (en) Novel compounds
GB9918208D0 (en) Novel compounds
WO2000042191A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
GB9918003D0 (en) Novel compounds
GB9918206D0 (en) Novel compounds
GB9914945D0 (en) Novel compounds
GB9918281D0 (en) Novel compounds
AU1383901A (en) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application